以“研以致用”铸壁垒:重组胶原蛋白第一股巨子生物的周期破局之道

中金在线
Jul 28

当下,中国美妆行业正面临从营销驱动到技术竞争的深刻转型,当概念性成分的狂欢褪去,核心原料自主化与研发精准化成为破局关键。在这场变革中,“重组胶原蛋白第一股”巨子生物的突围路径颇具启示。巨子生物首席技术官段志广博士以“研以致用”的精准研发体系,构建起从基础研究到产业落地的全链路闭环,不仅为企业筑起护城河,更重新定义了本土美妆的创新标准。精准研发:重构行业从“跟风”到“创造”的底层逻辑在成分内卷的行业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10